Mirum Pharmaceuticals, Inc. MIRM Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s net income?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net income of -$790.16M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s net income changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net income decreased by 5283.6% year-over-year, from -$14.68M to -$790.16M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net income?
- Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s net income has grown at a -44.4% compound annual growth rate (CAGR), from -$135.67M to -$23.36M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.